Standout Papers

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and... 2009 2026 2014 2020 2.9k
  1. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes (2009)
    James W. Vardiman, Jüergen Thiele et al. Blood
  2. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study (2009)
    Pierre Fenaux, Ghulam J. Mufti et al. The Lancet Oncology
  3. Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia (2009)
    Pierre Fenaux, Ghulam J. Mufti et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 23 from Science/Nature 92 standout
Sub-graph 1 of 16

Citing Papers

Regulation and functions of non-m6A mRNA modifications
2023 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
27 intermediate papers

Works of Eva Hellström‐Lindberg being referenced

TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression
2011
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
and 19 more

Author Peers

Author Last Decade Papers Cites
Eva Hellström‐Lindberg 8074 3759 3952 184 10.4k
Aristoteles Giagounidis 8318 3617 3279 253 10.0k
Peter L. Greenberg 8955 3718 3105 200 10.8k
Azra Raza 8686 3501 5409 273 12.1k
Ghulam J. Mufti 7547 2895 3958 268 11.0k
Steven D. Gore 6114 2064 3499 217 7.9k
Tessa L. Holyoake 7343 4623 3745 216 10.9k
Ulrich Germing 5254 2333 2347 245 6.9k
Paresh Vyas 4947 1774 4372 229 9.2k
Christian Récher 4738 1735 4219 288 8.6k
Anna Porwit 4269 2540 2129 173 7.1k

All Works

Loading papers...

Rankless by CCL
2026